BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8135186)

  • 1. Bone marrow involvement in large-cell lymphoma. Prognostic implications of discordant disease.
    Hodges GF; Lenhardt TM; Cotelingam JD
    Am J Clin Pathol; 1994 Mar; 101(3):305-11. PubMed ID: 8135186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
    Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
    Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.
    Robertson LE; Redman JR; Butler JJ; Osborne BM; Velasquez WS; McLaughlin P; Swan F; Rodriguez MA; Hagemeister FB; Fuller LM
    J Clin Oncol; 1991 Feb; 9(2):236-42. PubMed ID: 1988571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse large cell lymphoma with discordant bone marrow histology. Clinical features and biological implications.
    Fisher DE; Jacobson JO; Ault KA; Harris NL
    Cancer; 1989 Nov; 64(9):1879-87. PubMed ID: 2790699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Park MJ; Park SH; Park PW; Seo YH; Kim KH; Seo JY; Jeong JH; Kim MJ; Ahn JY; Hong J
    J Clin Pathol; 2015 Sep; 68(9):733-8. PubMed ID: 25998512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index.
    Chung R; Lai R; Wei P; Lee J; Hanson J; Belch AR; Turner AR; Reiman T
    Blood; 2007 Aug; 110(4):1278-82. PubMed ID: 17475910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
    Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
    J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens.
    Arber DA; George TI
    Am J Surg Pathol; 2005 Dec; 29(12):1549-57. PubMed ID: 16327427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
    Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
    Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
    Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders.
    Kremer M; Spitzer M; Mandl-Weber S; Stecker K; Schmidt B; Höfler H; Quintanilla-Martínez L; Fend F
    Lab Invest; 2003 Jan; 83(1):107-14. PubMed ID: 12533691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow involvement by non-Hodgkin's lymphom.
    Lee WI; Lee JH; Kim IS; Lee KN; Kim SH
    J Korean Med Sci; 1994 Oct; 9(5):402-8. PubMed ID: 7702789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.
    Juneja SK; Wolf MM; Cooper IA
    J Clin Pathol; 1990 Aug; 43(8):630-2. PubMed ID: 2401730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the bone marrow by non-Hodgkin's lymphomas: incidence, histology and pathologic correlations.
    Baroni CD; Manente L; Occhionero M; Marzullo A; Mandelli F; Biagini C
    Tumori; 1981; 67(3):191-6. PubMed ID: 7025400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow involvement in non-Hodgkin's lymphoma.
    Lai HS; Tien HF; Hsieh HC; Chen YC; Su IJ; Wang CH; Liu MC; Cheng AL; Shen MC; Liu CH
    Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):114-21. PubMed ID: 2769211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.
    Yan Y; Chan WC; Weisenburger DD; Anderson JR; Bast MA; Vose JM; Bierman PJ; Armitage JO
    J Clin Oncol; 1995 Jun; 13(6):1336-42. PubMed ID: 7751877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.